Prevalence of HTLV-I-associated T-cell lymphoma
β Scribed by B.J. Poiesz; L.D. Papsidero; G. Ehrlich; M. Sherman; S. Dube; M. Poiesz; K. Dillon; F.W. Ruscetti; D. Slamon; C. Fang; A. Williams; D. Duggan; J. Glaser; A. Gottlieb; J. Goldberg; L. Ratner; P. Phillips; T. Han; A. Friedman-Kien; F. Siegal; K. Rai; A. Sawitsky; L.W.A. Sheremata; H. Dosik; C. Cunningham; R. Montagna
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 48 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
β¦ Synopsis
In order to assess the prevalence rate of HTLV-I-associated T-cell lymphomas and human retrovirus infection in general, approximately 21,000 individuals representing various patient populations, retroviral risk groups, and blood donors were examined for HTLV-I, HTLV-II, HIV-1, or HIV-2 infection using serologic and PCR assays. The prevalence rates among volunteer blood donors were 0.02% and 0% for HTLV and HIV, respectively. Significantly increased HTLV prevalence rates were observed among paid blood donors, African American health care clinic patients, Amerindians, recipients of HTLV-positive cellular blood products, intravenous drug users, sexual contacts and family members of HTLV-positive people, and patients with primary thrombocytosis and other-than-lowgrade non-Hodgkin's lymphoma (NHL). Among some of these groups there were significant differences in the prevalence of HTLV-I versus HTLV-II. The eight HTLV-positive NHL patients all had mature, high-grade, CD4 + T-cell lymphomas with clonally integrated HTLV-I, for a prevalence of 4% among other-than-low-grade NHL patients. Seven of the eight died from their disease within 2 years despite treatment. Interestingly, two groups at risk for HTLV infection, namely needle stick victims and recipients of HTLV-infected and/or pooled plasma products, showed no evidence for infection. Significantly increased HIV-1 prevalence was observed among paid blood donors, African Americans, homosexuals, female prostitutes, hemophiliacs, and other-than-low-grade NHL patients. Only one patient was infected with HIV-2. Of the nine HIV-positive, other-than-low-grade NHL patients, seven HIV-1 positives had B-cell lymphomas, one HIV-1 positive had an HTLV-I-positive CD4 + T-cell lymphoma, and one infected with HIV-2 had a CD4 + T-cell lymphoma that was HTLV negative. The data indicate that HTLV-I lymphoma, while uncommon, is not necessarily rare among other-than-low-grade NHL cases in the United States and, given its poor prognosis, should probably be studied separately in clinical trials. Am.
π SIMILAR VOLUMES
## Background: Adult t-cell leukemia/lymphoma (atll) is a neoplasm of the mature helper t-lymphocyte. human t-lymphotropic virus type 1 (htlv-1) has been shown to be the cause of this neoplasm. recently, however, the htlv-1 genome has been found in some patients with cutaneous t-cell lymphoma (ctcl
Patterns of HTLV-I infection among family members
To estimate the replication of the human T-cell leukemia virus type I (HTLV-I) in patients with HTLV-I-associated myelopathy (HAM), or tropical spastic paraparesis (TSP), HTLV-I DNA integrated into lymphocyte genomes was analyzed by Southern blot hybridization. HTLV-I DNA was detected in 125 (82%) o
We report a case of T-cell lymphoma showing in the peripheral blood (PB) exclusively T-lymphocytes with suppresser T-cell preponderance and a high percentage of natural killer (NK) marker positive cells by flow cytometry. A T-cell receptor (TCR) gene analysis of the PB leukocytes demonstrated rearra